Letter to the Editor

Vitamin D Levels in Patients Seen in the Diabetes Unit of an Academic Medical Center

Authors: Kanakasabai Narasimhan, MD, FACP, Ali A. Rizvi, MD, FACP, FACE

Abstract

To the Editor:


Although several studies have looked at vitamin D status in patients with diabetes, there is a paucity of data from practices specializing predominantly in diabetes. We assessed 25-hydroxyvitamin (OH) D levels in 133 patients (116 with type 2 and 17 with type 1 diabetes) seen in an outpatient diabetes unit of an academic medical center. Patients who had advanced congestive heart failure (New York Heart Association stage III and IV), active malignancy, stage 5 kidney disease, known vitamin D deficiency, or derangements of calcium-parathyroid metabolism were excluded. The group included 52 men and 81 women (89 Caucasian, 39 African American, and 5 Asian) with an average age of 54 years. Mean serum calcium was 9.45 mg/dL (reference range 8.6 to 10.2), average glycosylated hemoglobin (HbA1c) was 6.9%, mean serum creatinine was 1.06 mg/dL (reference range 0.5 to 1.3), and the majority (38/133, or 71.4%) had estimated glomerular filtration rate (eGFR) values greater than 60 mL/min. Following a recently proposed classification,1 68 patients (51.1%) were “deficient” (≤20 ng/mL), 32 patients (24%) were “relatively insufficient” (21–29 ng/mL), and only 33 patients (24.8%) qualified as having “sufficient” 25 (OH) vitamin D levels (≥30 ng/mL).

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281.
 
2. Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500–1503.
 
3. de Boer IH, Tinker LF, Connelly S, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women’s Health Initiative. Diabetes Care 2008;31:701–707.
 
4. Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J 2006;53:503–510.
 
5. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 2008;168:771–772.